Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develops CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting…more
Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develops CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting…more
Analyst consensus: Buy
As of 21 Jul 2026, 1 analyst rate Creo Medical Group PLC a Buy, with 100% buy ratings and a mean price target of 55p (range 40p–70p), +296% vs the current price.